Practice Location

1388 COURT ST
REDDING, CA 96001-1660

Phone: (530) 246-2207

What does KIMBERLY PAGE research?

Dr. Page's research primarily examines the health outcomes of individuals dealing with substance use disorders, violent injuries, and maternal health. For instance, she investigates how young patients in emergency departments connect with the criminal justice system after suffering violent injuries, revealing that one-third of these patients have previous legal involvement. Additionally, she studies the experiences of patients with obesity and obstructive sleep apnea, exploring their treatment preferences for effective management strategies. Through her work with certified nurse-midwives, she highlights the benefits of midwifery care in improving maternal health outcomes and reducing healthcare disparities.

Key findings

  • 33% of young patients treated for violent injuries in an emergency department had prior involvement with the criminal legal system.
  • In a review of 66 studies, certified nurse-midwife and certified midwife care led to lower cesarean rates and improved patient satisfaction compared to traditional physician care.
  • 48% of patients with obesity and obstructive sleep apnea preferred the weight-loss medication tirzepatide over the traditional CPAP treatment, which was favored by 21% of patients.
  • Among people who inject drugs receiving hepatitis C treatment, achieving sustained virological response (SVR) led to a significant reduction in hazardous alcohol use.
  • Home upgrades in low-income households led to improved physical and mental health outcomes, with participants reporting less breathlessness and fewer doctor visits.

Frequently asked questions

Does Dr. Page study the health impacts of substance use?
Yes, Dr. Page conducts extensive research on how addiction, particularly opioid use and methamphetamine toxicity, affects health outcomes and treatment preferences.
What treatments has Dr. Page researched for obesity and obstructive sleep apnea?
Dr. Page has compared patient preferences for treatment options, particularly continuous positive airway pressure (CPAP) versus the weight-loss medication tirzepatide.
Is Dr. Page's work relevant to patients recovering from violent injuries?
Absolutely, her research highlights the prevalence of criminal legal involvement among young patients treated for violent injuries and emphasizes the need for targeted support to prevent further violence.

Publications in plain English

Identification of actionable targets using DEPArray-based sorting of pure carcinoma and stromal populations from formalin-fixed paraffin-embedded tissues followed by shallow whole-genome sequencing.

2026

The Journal of pathology

Nteliopoulos G, Wren E, Rushton A, Wadsley MK, Fernandez-Garcia D +16 more

Plain English
This study looked at how to get useful genetic information from cancer tissue samples that have been preserved in a special way, which often makes the DNA hard to use. Researchers successfully used a method to isolate pure cancer cells from 12 samples, mainly from breast and ovarian cancers. Out of these, 70% provided quality genetic data, allowing them to find important mutations and changes linked to potential treatments, such as issues with genes like PIK3CA and BRCA1/2. Who this helps: This benefits cancer patients by identifying targeted treatment options based on their specific genetic changes.

PubMed

Influence of Compositional Complexity on Amorphization Resistance of Swift Heavy Ion Irradiated Titanate Pyrochlores.

2026

Inorganic chemistry

Adamson G, Hirtz JM, Overstreet C, O'Quinn E, Kinsler-Fedon C +8 more

Plain English
This study looked at two complex materials, called pyrochlore oxides, to see how they react when exposed to high-energy particle radiation. Researchers found that both materials lost their structured form, but one material, (YbErDyTbGd)TiO, had larger areas of disordered material compared to the other, HoTiO. Understanding how these materials behave in harsh conditions is important because they can be used in applications like nuclear waste storage and protective coatings. Who this helps: This benefits engineers and scientists working on materials for extreme environments.

PubMed

Social, Economic, and health risks among people who use Methamphetamine: Comparing three patterns of opioid Co-Use.

2026

Addictive behaviors reports

Page K, Kirk MR, Garcia T, Etchart H, Chase B +8 more

Plain English
This study looked at how different ways of using methamphetamine and opioids affect people's social lives, health, and economic situations. Out of 414 surveyed drug users in Nevada and New Mexico, 53.1% used both drugs at the same time, 17.7% used them one after the other, and 29.2% used meth alone or with non-opioids. The research found that those who used meth and opioids simultaneously faced more serious social and health risks, highlighting the importance of creating strategies to help people switch to safer drug use habits. Who this helps: This helps patients who are struggling with drug use by informing better treatment options.

PubMed

Symptom Profiles and Characteristics of Acute Methamphetamine Toxicity: Implications for Emergency Recognition and Response.

2026

Academic emergency medicine : official journal of the Society for Academic Emergency Medicine

Wagner KD, Chase B, Anderson J, Andres Reyes MS, Harding RW +2 more

Plain English
This study looked at the symptoms and experiences of people who had toxic reactions to methamphetamine compared to those who overdosed on opioids or used multiple drugs. Out of 420 surveyed individuals, 24% reported only methamphetamine toxicity, showing symptoms like anxiety (43%) and rapid heart rate (33%), while opioid overdoses mainly caused loss of consciousness (86%). Understanding these differences is important for improving emergency care for each type of overdose, especially since fewer people with methamphetamine toxicity had naloxone, a life-saving drug. Who this helps: This research benefits emergency responders and healthcare providers who treat drug overdoses.

PubMed

Impact of Social Drivers of Health, Self-Efficacy, and Substance Use on COVID-19 Preventative Behaviors Among Persons Who Inject Drugs with Hepatitis C: The HERO Study.

2026

International journal of environmental research and public health

Lopes SS, Pericot-Valverde I, Lum PJ, Taylor LE, Mehta SH +13 more

Plain English
This study focused on how social factors, confidence in one's ability to change, and substance use affected the ability of people who inject drugs and have hepatitis C to follow COVID-19 safety measures. It found that individuals facing social challenges, like unstable housing or jobs, were about 4.6 times more likely to struggle with practicing safe behaviors like handwashing and social distancing. In contrast, those with higher self-confidence were less likely to have these issues. This research highlights the importance of addressing social challenges and boosting confidence to help protect vulnerable populations during health crises. Who this helps: This helps patients who inject drugs and have hepatitis C.

PubMed

Treating Hepatitis C Within Real-world Telemedicine Addiction Care.

2026

Journal of addiction medicine

Lira MC, Hendy LE, Tsui JI, Page K, Jimes C +3 more

Plain English
Researchers studied how well hepatitis C treatment can be combined with telemedicine programs for people being treated for opioid use disorder (OUD). In a review of patient records, they found that out of 63 patients prescribed antiviral medication, about 52% completed their treatment, but nearly 20% were denied coverage for the medication. This is important because it shows that telehealth can effectively deliver hepatitis C treatment, but better insurance policies are needed to ensure more patients can access this critical care. Who this helps: This benefits patients suffering from both hepatitis C and opioid use disorder, as well as their healthcare providers.

PubMed

Achieving SVR is associated with long term reduced hazardous alcohol use for people who inject drugs receiving HCV treatment: The HERO study.

2026

Drug and alcohol dependence

Waters E, Obeysekare J, Lopes S, Pericot-Valverde I, Norton BL +12 more

Plain English
This study looked at how alcohol use changed for people who inject drugs and were treated for hepatitis C (HCV). Researchers found that those who successfully cleared the virus (called achieving sustained virological response, or SVR) showed a significant decrease in alcohol use during and after treatment, with reductions measured by a scoring system at various follow-up points. This is important because it suggests that treating HCV can also help people reduce harmful drinking, which benefits liver health. Who this helps: This helps patients who inject drugs and struggle with both HCV and alcohol use.

PubMed

Treatment preferences for comorbid obesity and obstructive sleep apnea (PRO-CON OSA) survey: Patient and provider preferences for CPAP and/or tirzepatide.

2026

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine

Schmickl CN, Tripipitsiriwat A, Mokhlesi B, Mallampalli M, Nokes B +16 more

Plain English
This study looked at how patients and healthcare providers prefer to treat people who have both obesity and obstructive sleep apnea, a condition affecting about 10% of US adults. It found that while 70% of both groups found continuous positive airway pressure (CPAP) and tirzepatide treatments acceptable, patients favored tirzepatide significantly more (48% preferred it over 21% for CPAP), while providers leaned towards CPAP (52% preferred it over 27% for tirzepatide). Understanding these preferences is crucial for developing better treatment plans that suit both patients' and providers' needs. Who this helps: This helps patients with obesity and sleep apnea as well as their healthcare providers.

PubMed

Demographic and Health Characteristics in Hispanic versus non-Hispanic Groups Experiencing Homelessness in New Mexico.

2026

Journal of racial and ethnic health disparities

Duran A, Aragon A, Phillips C, Page K,

PubMed

A Scoping Review of Certified Nurse-Midwife and Certified Midwife Care in the United States: Assessing Outcomes Across Six Patient Care Domains.

2026

The Milbank quarterly

Clark EV, Schafer R, Walden RL, Blumenfeld J, Neerland CE +4 more

Plain English
This research paper looked at the care provided by certified nurse-midwives (CNMs) and certified midwives (CMs) in the United States and compared it to traditional physician care across various healthcare quality areas. The study found that CNM/CM care often led to better or similar outcomes, such as lower cesarean rates and improved patient satisfaction, across 66 studies. This is important because it shows that integrating CNM and CM care can improve maternal and reproductive health outcomes and reduce disparities in care. Who this helps: This benefits patients, especially those seeking maternity and reproductive care.

PubMed

High prevalence of criminal legal involvement among non-fatally injured ED patients - an exploratory retrospective observational cohort analysis.

2026

Health & justice

Eswaran V, Cohen R, Kaser T, Wurcel AG, Mancini M +5 more

Plain English
This study looked at young patients who were treated for violent injuries in a hospital in St. Louis. It found that 33% of these patients had been involved with the criminal legal system, and those individuals were often young men without health insurance, relying on emergency care. This is important because it shows a link between past criminal involvement and experiencing violent injuries, highlighting the need for targeted efforts to prevent future violence and better support these individuals after their injuries. Who this helps: This helps patients recovering from violent injuries, healthcare providers, and community programs focused on violence prevention.

PubMed

Minimum information for reporting on the TEER (trans-epithelial/endothelial electrical resistance) assay (MIRTA).

2025

Archives of toxicology

Sharma M, Huber E, Arnesdotter E, Behrsing HP, Bettmann A +31 more

Plain English
This study focused on how to standardize the reporting of the TEER (trans-epithelial/endothelial electrical resistance) assay, which is used to check the health of cell cultures and assess potential toxicity. The researchers reviewed protocols from twelve laboratories and created clear guidelines to improve consistency in the way results are reported. These guidelines will help ensure that data is more reliable and can be easily compared across different labs, ultimately enhancing the quality of research. Who this helps: This helps researchers and laboratories working on respiratory health research.

PubMed

Current Self-reported Pain Before and After Cure of Hepatitis C Among Persons Who Actively Inject Drugs.

2025

Journal of addiction medicine

Tsui JI, Ludwig-Barron NT, James JR, Heo M, Sivaraj LB +10 more

Plain English
This study looked at whether curing hepatitis C reduces pain in people who inject drugs. Out of 501 participants, 35% reported moderate or severe pain before treatment. While those who were cured didn't show lower pain levels overall, pain did decrease for those with higher pain levels at the start after treatment, except for those who didn't get cured, who reported more pain after treatment. Who this helps: This helps patients who inject drugs, especially those dealing with chronic pain.

PubMed

A qualitative systematic review of the impact of hearing on quality of life.

2025

Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation

Henderson N, Hodgson S, Mulhern B, Page K, Sampson C

Plain English
This study looked at how hearing problems affect the quality of life for adults by reviewing findings from 22 studies with around 450 participants. The researchers found that hearing issues impact several areas: physically (like fatigue and clarity), mentally (including anxiety and identity), and socially (such as communication and relationships). Understanding these impacts is important for creating better tools to measure how hearing loss affects people's lives. Who this helps: This benefits patients with hearing loss and their healthcare providers.

PubMed

Redefining low-threshold buprenorphine access in an integrated mobile clinic program: Factors associated with treatment retention.

2025

Journal of substance use and addiction treatment

Harris R, Stracker N, Rice M, St Clair A, Page K +1 more

Plain English
Researchers studied how changes in a mobile clinic program could help people with opioid addiction stick with their buprenorphine treatment in Baltimore. They found that after making changes—like giving longer prescriptions and using telemedicine—60% of patients stayed in treatment for at least 90 days. Additionally, patients receiving higher doses of buprenorphine (28 to 32 mg daily) were 80% less likely to stop treatment compared to those getting lower doses. This research is important because it shows that making treatment more accessible and integrating other health services can improve patient retention in care. Who this helps: This helps patients struggling with opioid addiction, particularly those with complex health needs.

PubMed

The Pediatric Influence of Cooling Duration on Efficacy in Cardiac Arrest Patients (P-ICECAP): Statistical Methods Planned in the Bayesian, Adaptive, Duration Finding Trial.

2025

Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies

VanBuren JM, Yeatts SD, Holubkov R, Moler FW, Topjian A +3 more

Plain English
This study, called P-ICECAP, looked at how long to cool children who have had a cardiac arrest outside the hospital to improve their chances of recovery. Researchers tested different cooling times ranging from no cooling to 96 hours, with the goal of finding the best duration that helps kids recover. The study involves up to 900 young patients and aims to discover the shortest cooling time that still leads to the best overall outcomes after one year, using various assessments to measure their progress. Who this helps: This helps children who experience cardiac arrest and their healthcare providers.

PubMed

Defining Midwifery-Led Care in the United States Using Concept Analysis.

2025

Journal of midwifery & women's health

Page K, Phillippi J, Emeis CL, Cummins A, Thumm B

Plain English
This research paper explored the idea of midwifery-led care in the United States, which means having midwives take the lead in providing care to mothers and newborns. The study found that midwifery-led care can lead to better health outcomes for mothers and babies, higher patient satisfaction, and lower healthcare costs. It established three key aspects of this care model: that midwives are the main caregivers, that they build partnerships with their patients, and that their care follows the principles of midwifery. Who this helps: This benefits patients, especially mothers and newborns seeking safer and more supportive care during pregnancy and childbirth.

PubMed

Modeling of randomized hepatitis C vaccine trials: Bridging the gap between controlled human infection models and real-word testing.

2025

PNAS nexus

Mackesy-Amiti ME, Gutfraind A, Tatara E, Collier NT, Cotler SJ +5 more

Plain English
This study looked at how to test hepatitis C vaccines more effectively for people who inject drugs (PWID). Researchers created a model to simulate a two-dose vaccine for 32,000 PWID in Chicago, finding that the vaccine could be about 48% to 72% effective in preventing infections. This research is important because it improves the chances of successfully finding effective vaccines in real-world settings, which is crucial for controlling hepatitis C. Who this helps: Patients, especially those who inject drugs, and public health officials.

PubMed

Finding the right dose: a scoping review examining facilitation as an implementation strategy for evidence-based stroke care.

2025

Implementation science : IS

Fasugba O, Cheng H, Dale S, Coughlan K, McInnes E +13 more

Plain English
This review examined how facilitating the implementation of effective stroke care practices affects patient outcomes in hospitals and rehabilitation settings. Out of 649 studies, only 10 provided relevant information, but only two clearly stated how much facilitation was used, showing that details about facilitation strategies were often missing. Clearer information about how facilitation is done could help improve stroke care and ensure more patients receive effective treatments. Who this helps: This helps patients and healthcare providers by improving stroke care practices.

PubMed

Implementing a Patient-Centered, Rapid-Access Substance Use Treatment Pathway in Primary Care.

2025

Psychiatric services (Washington, D.C.)

Jeansonne S, Dopp AR, Phillips C, Cook M, Brown L +3 more

Plain English
This study focused on improving access to substance use treatment in primary care clinics by creating a quick and easy process for patients seeking help. Researchers found that by offering immediate telehealth appointments, they significantly increased treatment access rates and made it easier for patients to get ongoing care without disrupting clinic operations. This matters because it shows a practical way to ensure more people receive the help they need for substance use disorders. Who this helps: This helps patients struggling with substance use disorders.

PubMed

Risk Factors for Viral Coinfections in Blood Donors in Bahia, Brazil.

2025

Journal of medical virology

Luz E, Marques M, Arriaga MB, Campos LM, Lima L +4 more

Plain English
This study looked at blood donations in Bahia, Brazil, to understand the risk factors for people having multiple viral infections (coinfections) like HIV, hepatitis B (HBV), and hepatitis C (HCV). Out of nearly 780,000 blood donations, 3.5% tested positive for infections, with 2.4% having multiple infections. Notably, male donors, those with lower education, single status, and first-time donors had a higher risk of both single infections and coinfections, but the risk was significantly greater for coinfections. Who this helps: This information benefits blood banks and healthcare providers in managing safe blood donations and transfusions.

PubMed

Improvement in anxiety symptoms during treatment of Hepatitis C in people who inject drugs: The HERO study.

2025

Drug and alcohol dependence

Obeysekare J, Pericot-Valverde I, Lopes S, Groome M, Norton BL +10 more

Plain English
This study looked at how anxiety levels changed in people who inject drugs while they were treated for Hepatitis C. Researchers found that overall, anxiety decreased significantly during treatment, especially in those who achieved a good response to the therapy; specifically, anxiety scores dropped consistently across several time points for patients who were successfully treated. This is important because it shows that treating Hepatitis C can also help reduce anxiety for this vulnerable group of patients. Who this helps: Patients with Hepatitis C who inject drugs.

PubMed

Outcomes from the Victorian Healthy Homes Program: a randomised control trial of home energy upgrades.

2025

BMJ open

Page K, Hossain L, Liu D, Kim YH, Wilmot K +9 more

Plain English
The Victorian Healthy Homes Program studied the effects of home energy upgrades on the health and comfort of older, vulnerable individuals during winter in Victoria, Australia. The upgrades, which cost about $2,800 per household, led to a 0.33°C increase in indoor temperatures, reduced gas consumption by 25.5 megajoules per day, and decreased exposure to cold by nearly 43 minutes each day. Participants also reported better mental health and lower healthcare costs, averaging $887 less per person during the winter. Who this helps: This benefits older patients and vulnerable households living in cold conditions.

PubMed

Patient-navigator working alliance and hepatitis C treatment cascade outcomes among persons who inject drugs: The HERO study.

2025

Drug and alcohol dependence

Lopes SS, Dotherow JE, Pericot-Valverde I, Lum PJ, Taylor LE +14 more

Plain English
This study looked at how the relationship between patients and their navigators (helpers who guide them through treatment) affects the success of hepatitis C treatment in people who inject drugs. It found that when patients have a strong bond with their navigator, they are six times more likely to achieve a cure for hepatitis C compared to those with weaker relationships. This is important because improving this alliance can help more people effectively get treated and cured of hepatitis C, which affects many individuals in this population. Who this helps: This helps patients who inject drugs by increasing their chances of successfully treating hepatitis C.

PubMed

Promoting inclusion in COVID-19 research for diverse Hispanic/Latino(x) populations: Recommendations from the RADx® Underserved Populations Hispanic/Latino/Latinx working group.

2025

Journal of clinical and translational science

Gonzalez-Guarda RM, Acosta-Perez E, Adames C, Bailey R, Carvajal-Carmona L +5 more

PubMed

Four-rod technique for neuromuscular scoliosis and pelvic obliquity correction: technical note and case series.

2025

European journal of orthopaedic surgery & traumatology : orthopedie traumatologie

Moreno Mateo F, Heyer JH, Gmelich C, Page K, Cirrincione P +3 more

Plain English
This study looked at a new surgical method called the four-rod technique to help correct spinal curves and pelvic tilts in patients with neuromuscular scoliosis. Five patients who underwent this procedure saw a significant improvement in their deformities right after surgery, which was maintained over time, with follow-up periods ranging from 2 to 16 years. This approach simplifies the surgery by eliminating the need for additional traction during the operation, making it a promising option for better outcomes. Who this helps: Patients with neuromuscular scoliosis.

PubMed

Hospital Addiction Consultation Service and Opioid Use Disorder Treatment: The START Randomized Clinical Trial.

2025

JAMA internal medicine

Ober AJ, Murray-Krezan C, Page K, Friedmann PD, Anderson J +12 more

Plain English
This study examined whether a specialized hospital service called the Substance Use Treatment and Recovery Team (START) could help patients with opioid use disorder (OUD) start treatment while in the hospital and find ongoing care afterwards. The results showed that 57.3% of patients in the START group began treatment with medications, compared to only 26.7% in the usual care group, and 72.0% of START patients linked to follow-up care after discharge versus 48.1% for usual care. These findings are significant because they demonstrate that dedicated support can dramatically improve access to effective treatment for opioid addiction in hospitals. Who this helps: This benefits patients with opioid use disorder.

PubMed

Efficacy and Safety of Zimlovisertib, Ritlecitinib, and Tofacitinib, Alone and in Combination, in Patients With Moderate to Severe Rheumatoid Arthritis and an Inadequate Response to Methotrexate.

2025

Arthritis & rheumatology (Hoboken, N.J.)

Danto SI, Salganik M, Banerjee A, Hrycaj P, Jashi I +7 more

Plain English
This study looked at how effective and safe a new treatment called zimlovisertib is when combined with either ritlecitinib or tofacitinib, compared to using tofacitinib alone in patients with moderate to severe rheumatoid arthritis who were not responding well to methotrexate. After 12 weeks, patients who took the combination of zimlovisertib and tofacitinib showed a significant improvement in their disease activity score, with an average reduction of 2.65 points compared to a 2.30 point reduction for those on tofacitinib alone. Overall, 53.5% of patients experienced side effects, but most were mild, and all treatments were generally well tolerated. Who this helps: This research benefits patients with moderate to severe rheumatoid arthritis looking for more effective treatment options.

PubMed

Retreatment of Hepatitis C Virus Among People Who Inject Drugs.

2025

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Thomas AM, Litwin AH, Tsui JI, Sprecht-Walsh S, Blalock KL +14 more

Plain English
This study looked at how well people who inject drugs (PWID) respond to treatment for the Hepatitis C virus (HCV) after not getting better the first time or getting reinfected. Out of 104 participants eligible for retreatment, only 43 started it, but an impressive 96% of those who began retreatment successfully cleared the virus. This is important because it shows that providing PWID with quicker access to treatment can significantly improve health outcomes and help reduce the spread of HCV. Who this helps: This helps patients with Hepatitis C, particularly those who inject drugs.

PubMed

Essential service accessibility and contribution to quality of life: a systematic review.

2025

BMC public health

Wood SM, Page K, Baker E, Beks H, Binder MJ +3 more

Plain English
This study looked at what "essential services" are in Australia and how they relate to people's quality of life. Out of 1,473 studies reviewed, seven provided useful information, highlighting that services that promote social connections, like food and health services, have the biggest positive effects on well-being. However, there is confusion about which services should be classified as essential, making it hard to draw firm conclusions. Who this helps: This helps policymakers and urban planners in improving community access to essential services.

PubMed

A Compassionate Release Pilot in New Orleans.

2025

Journal of correctional health care : the official journal of the National Commission on Correctional Health Care

Stanley C, Sonderegger K, Tucker C, Kumar N, Boniske T +2 more

Plain English
This study looked at how to better help elderly and seriously ill prisoners in New Orleans get released to receive care instead of staying in jail. They found that out of 18 eligible patients between August 2022 and December 2023, only four were actually released, while eight died in prison, and six stayed locked up. This matters because a coordinated effort between health care providers and legal teams can significantly improve the chances of compassionate release for those who need it most. Who this helps: This helps patients who are terminally ill or disabled and their families.

PubMed

Challenges in coverage of future hepatitis C vaccines: Review and potential solutions.

2025

Vaccine

Gandhi K, Vijay Y, Page K, Dahari H, Gutfraind A

Plain English
This paper studied the potential challenges of rolling out a vaccine for hepatitis C, focusing on the specific barriers faced by people who inject drugs. The authors identified six major issues, such as concerns about vaccine safety and misinformation, which could hinder vaccine acceptance, especially considering that these individuals are at a higher risk of infection. They also offered four recommendations to improve vaccination efforts, including targeted educational campaigns and community support programs, which could help achieve the goal of eliminating hepatitis C by 2030. Who this helps: This helps patients, particularly those who inject drugs, by promoting access to effective vaccination and reducing their risk of hepatitis C.

PubMed

An ASTCT, CIBMTR, EBMT, and APBMT Consensus Statement Defining Response Criteria for Hematopoietic Cell Transplantation Associated Thrombotic Microangiopathy (TA-TMA) Directed Therapy.

2025

Transplantation and cellular therapy

Schoettler ML, Gavriilaki E, Carreras E, Bo-Kyoung C, Dandoy CE +16 more

Plain English
Researchers studied a condition called transplant-associated thrombotic microangiopathy (TA-TMA), which can significantly harm patients after blood stem cell transplants. They gathered experts from different transplant groups to come up with clear guidelines on how to measure the effectiveness of treatments for this condition. The experts proposed key criteria for assessing responses to therapy, emphasizing the importance of recognizing partial improvements, particularly since complete recovery may take time, especially for patients with damage to their organs. Who this helps: This helps patients undergoing hematopoietic cell transplants and their healthcare providers.

PubMed

Evaluation of a Region-Wide Hospital-Based Violence Intervention Program : A Pilot Cohort Study.

2025

Annals of internal medicine

Mueller KL, Kaser TM, Cooper BP, Lew D, Moran V +20 more

Plain English
This study looked at a program called Life Outside of Violence (LOV) in the St. Louis area, designed to help people who have survived violent injuries. Out of 3,744 eligible patients, only 233 chose to join the program, and researchers followed 198 of those participants for a year. They found that the likelihood of getting injured again was similar for both the LOV participants (7.6%) and those who did not enroll in the program (7.4%), suggesting that the program might not significantly reduce the risk of reinjury. Who this helps: This information is useful for healthcare providers and organizations addressing violence prevention.

PubMed

Insights from the development of an online toolkit to promote community engaged substance use research in the Southwest Borderlands Region.

2025

Research square

Gorvetzian A, Sanchez M, Phillips C, Allbright J, Yonkovig A +6 more

Plain English
This study focused on creating an online resource called the EXPLORE Toolkit to help researchers and community workers engage with underrepresented groups regarding substance use in the Southwestern United States. The toolkit received strong support, with 79% of users deeming it "Very important" for promoting respectful research practices, and showed positive impacts like increased willingness to participate in research (from an average of 7.19 to 7.94 out of 10). This is significant because it helps ensure that more diverse voices are included in clinical research, which can lead to better health outcomes in affected communities. Who this helps: This benefits patients and communities dealing with substance use issues.

PubMed

NETSseq reveals inflammatory and aging mechanisms in distinct cell types, driving cerebellar decline in ataxia telangiectasia.

2025

Frontiers in neuroscience

Stirparo GG, Xu X, Thompson T, Page K, Harvey JRM +19 more

Plain English
This study focused on understanding the brain changes in people with ataxia-telangiectasia (A-T), a rare genetic disorder that causes severe neurological problems. The researchers found that certain brain cells, called granule neurons, showed disrupted communication affecting movement, while other cells (astrocytes and microglia) showed signs of premature aging and stress. This is important because it sheds light on the underlying causes of motor difficulties in A-T and helps develop targeted treatments for neurodegenerative diseases. Who this helps: This helps patients with ataxia-telangiectasia and their doctors.

PubMed

Clinical outcomes of dolutegravir treatment in people living with HIV in Brazil: protocol for the CODE cohort.

2025

BMC infectious diseases

Brites C, Luz E, Stelitano C, Bahia F, de Lacerda MVG +21 more

Plain English
The CODE study looked at how effective and safe the HIV medication Dolutegravir (DTG) is for people in Brazil. Researchers are tracking about 5,000 participants over three years to see how many stop taking DTG due to side effects, as well as how well the treatment helps control the virus. They found that detailed real-world experiences with DTG can improve HIV treatment strategies, which is important for many people living with HIV. Who this helps: This helps patients living with HIV, doctors, and healthcare providers improve treatment options.

PubMed

Rethinking pain: a paradigm shift in primary care for chronic pain via community-based, culturally-responsive GP support.

2025

Pain management

Jamil S, Page K, Suleman A, Tabasam G, Thompson K +1 more

Plain English
This research paper focused on how general practitioners (GPs) can improve their approach to treating chronic pain, particularly by using community resources and adopting a more holistic perspective. The study highlighted a program in Bradford, England, which helped GPs learn to identify chronic pain early and guide patients toward non-medical support options. By changing the way GPs think about pain management, this program can lead to fewer unnecessary appointments and better overall care for patients. Who this helps: This helps patients suffering from chronic pain by providing them with more effective and supportive care options.

PubMed

Depression profiles and hepatitis C treatment outcomes among people who inject drugs: The HERO study.

2025

Journal of psychosomatic research

Pericot-Valverde I, Lopes SS, Obeysekare J, Batchelder AW, Groome M +13 more

Plain English
This study looked at how different types of depression affect people who inject drugs and are being treated for hepatitis C. Researchers found three groups: one with no depression symptoms, one with sleep and appetite issues, and another with many symptoms but no suicidal thoughts. It was noted that those who did not get cured of hepatitis C continued to experience higher levels of depression. This is important because it highlights the need for doctors to pay close attention to and treat depression in these patients during their hepatitis C treatment. Who this helps: This helps patients undergoing hepatitis C treatment and their healthcare providers.

PubMed

Glycoprotein non-metastatic melanoma protein B is a biomarker of inflammation in individuals with Gaucher disease: relationship to clinico-pathological subtypes.

2025

Orphanet journal of rare diseases

Kilavuz S, Wallom KL, Caçote ACGAA, Donald A, D'Amore S +12 more

Plain English
This study looked at a protein called gpNMB in people with Gaucher disease (GD) to see if it could help understand inflammation and disease progression. Researchers found that gpNMB levels were much higher in patients with Gaucher disease (averaging 200.9 ng/ml) compared to healthy individuals (averaging 35.1 ng/ml), and this increase was especially noted in those with certain complications like liver or lung disease. Understanding gpNMB's role could help doctors monitor inflammation and disease activity in Gaucher patients. Who this helps: This benefits patients with Gaucher disease and their healthcare providers.

PubMed

Correction: Glycoprotein non-metastatic melanoma protein B is a biomarker of inflammation in individuals with Gaucher disease: relationship to clinico-pathological subtypes.

2025

Orphanet journal of rare diseases

Kilavuz S, Wallom KL, Caçote ACGAA, Donald A, D'Amore S +12 more

PubMed

Treatment Preferences For Comorbid Obesity and Obstructive Sleep Apnea (PRO-CON OSA) Survey: Patient and Provider Preferences for CPAP and/or Tirzepatide.

2025

medRxiv : the preprint server for health sciences

Schmickl CN, Tripipitsiriwat A, Mokhlesi B, Mallampalli M, Nokes B +15 more

Plain English
This study looked at how patients with obesity and obstructive sleep apnea (OSA) and their doctors feel about two treatment options: a traditional therapy called CPAP and a newer weight-loss medication called tirzepatide. The survey involved 461 patients and 114 healthcare providers and found that while 70% found both treatments acceptable, patients preferred tirzepatide (48%) over CPAP (21%), while providers preferred CPAP (52%) over tirzepatide (27%). Understanding these preferences is important for developing better treatment plans that cater to both patient needs and medical guidelines. Who this helps: This benefits patients with obesity and obstructive sleep apnea, as well as their doctors.

PubMed

Concurrent genomic assessment of circulating tumour cells and ctDNA to guide therapy in metastatic breast cancer.

2025

BMC cancer

Allsopp RC, Page K, Wren E, Nteliopoulos G, Gleason KLT +6 more

Plain English
This study looked at the DNA found in the blood of patients with advanced breast cancer to see if it could help doctors make better treatment decisions. Researchers collected and analyzed cell-free tumor DNA (cfDNA) and circulating tumor cells (CTCs) from eight patients, discovering that CTCs often provided valuable genetic information that wasn’t visible in cfDNA alone. Notably, changes in CTCs were found even when cfDNA results were negative, which could highlight important treatment options for doctors. Who this helps: This research helps both patients and doctors by providing more detailed information for personalized cancer treatment.

PubMed

Assessing endocrine resistance: monitoring circulating ESR1 mutations in Irosustat-treated ER positive breast cancer.

2025

Breast cancer research and treatment

Page K, Martinson LJ, Hastings RK, Acheampong E, Wadsley MK +5 more

Plain English
This study looked at the presence of specific mutations in the genes of patients with estrogen receptor-positive metastatic breast cancer who were treated with a combination of an aromatase inhibitor and the drug Irosustat. Out of 24 patients, 21 (88%) had at least one mutation found in their blood samples, with 76% having mutations in the ESR1 gene, which didn't clearly link to worsening disease. These results highlight the complexity of treating this type of cancer and suggest that careful patient selection is crucial for future therapies. Who this helps: Patients with estrogen receptor-positive metastatic breast cancer and their doctors.

PubMed

Health and well-being outcomes from a non-health population-level intervention: the impact of home upgrades in Victoria, Australia.

2025

Health and quality of life outcomes

Page K, Hossain L, Liu D, Kenny P, Van Gool K +2 more

Plain English
Researchers studied the impact of upgrading homes for energy efficiency and warmth in 1,000 low-income households in Victoria, Australia. They found that those who received home upgrades reported better physical and mental health and improved quality of life after winter compared to those who did not. Specifically, participants noted less breathlessness, needed fewer doctor visits, and felt more comfortable in their homes, indicating that even modest improvements in housing can lead to significant health benefits. Who this helps: This helps low-income families and older adults living in poor housing conditions.

PubMed

Getting to full disclosure: HCV testing and status disclosure behaviors among PWID and their injecting partners.

2025

BMC public health

Scarpetta M, Kanner R, Menezes NP, McDonell CC, Bruneau J +2 more

Plain English
The study looked at how often people who inject drugs (PWID) share their hepatitis C virus (HCV) test results with their injecting partners. It found that 91% of participants had been tested for HCV, with 57% reporting they were positive for the virus. Disclosure of HCV status was high overall at 79%, but it was more common among partners both infected (41%) than in mixed-status partnerships (17% for one positive and 32% for neither positive), highlighting the importance of open communication for preventing further infections and linking individuals to treatment. Who this helps: This information benefits both patients living with HCV and healthcare providers working to improve treatment and prevention efforts.

PubMed

Variability of Hepatitis C Treatment Cascade Outcomes among People Who Inject Drugs across Geographically Diverse Clinics in the US: The HERO Study.

2024

Viruses

Lopes SS, Heo M, Pericot-Valverde I, Norton BL, Taylor LE +10 more

Plain English
The HERO Study looked at how well hepatitis C treatments worked for people who inject drugs at 16 different clinics across the US. They found significant differences in treatment outcomes; for example, treatment initiation rates ranged from 68% to 96%, while the success rate in clearing the virus (known as sustained virologic response or SVR) varied from 46% to 90% depending on the specific criteria used. This variability shows that improvements are needed to make hepatitis C treatment more consistent and accessible for all patients. Who this helps: This helps patients who inject drugs and seek treatment for hepatitis C.

PubMed

Changes in Angiogenesis and Bone Turnover Markers in Patients with Gaucher Disease Developing Osteonecrosis.

2024

Metabolites

D'Amore S, Poole KE, Ramaswami U, Hughes D, Page K +5 more

Plain English
This study looked at patients with Gaucher disease, a condition that often leads to serious bone problems like osteonecrosis. Among 146 patients, they found that higher levels of a protein called MMP-9 predicted the development of osteonecrosis with 82% sensitivity and 75% specificity. Identifying patients at risk for this painful condition can help manage their care more effectively. Who this helps: This helps patients with Gaucher disease by allowing for earlier intervention and better treatment options.

PubMed

A digital companion for musicological scholarship: the Lohengrin TimeMachine.

2024

Journal of new music research

Dreyfus L, Lewis D, Page K

Plain English
This research paper introduces a new online tool called the "Lohengrin TimeMachine," designed to make music studies more accessible and engaging. It helps users explore and understand the use of musical themes in Wagner's opera by providing interactive features like a timeline that allows users to easily view and listen to different motifs throughout the opera. This matters because it breaks down the complexities of music research, making it easier for a broader audience to connect with and appreciate the material. Who this helps: This benefits music students, educators, and opera enthusiasts.

PubMed

The National Joint Registry Data Quality Audit of elbow arthroplasty.

2024

The bone & joint journal

Hamoodi Z, Shapiro J, Sayers A, Whitehouse MR, Watts AC +363 more

Plain English
This study looked at the accuracy and completeness of data collected about elbow surgeries in the National Joint Registry (NJR). Initially, they found over 5,500 surgeries that were not recorded in the NJR, with many being missing radial head surgeries. After a focused audit, the completeness of the data improved significantly, going from 63% to 83%, and the accuracy rose to 98%. Who this helps: This benefits patients undergoing elbow surgeries and doctors who rely on accurate data for treatment decisions.

PubMed

Frequent Co-Authors

Judith I Tsui Shruti H Mehta Lynn E Taylor Paula J Lum Judith Feinberg Arthur Y Kim Moonseong Heo Alain H Litwin Brianna L Norton

Physician data sourced from the NPPES NPI Registry . Publication data from PubMed . Plain-English summaries generated by AI. Not medical advice.